Causes and Treatments of Failed Back Surgery Syndrome

Ross Hauser, MD; Danielle Matias, PA-C; Demi Foster, APRN

“My surgeon says the fusion looks good, but I still cannot sit, stand, or walk comfortably.” “The leg pain improved, but my back still hurts.” “Now another operation is being recommended.” These concerns describe different problems, even though each may be called failed back surgery syndrome.

At Caring Medical, we see patients seeking additional options after spinal surgery. Our interest includes pain arising from spinal and pelvic ligaments, tendon attachments, and joints that may remain painful despite a technically successful operation. Ross Hauser, MD’s published work discusses lumbar instability and the rationale for considering Prolotherapy in selected patients. That perspective belongs within a broader assessment of why the pain persists.

Some patients need further surgical treatment. Others may benefit from rehabilitation, pain-directed treatment, or assessment of a previously unrecognized pain source. The useful starting question is: what is causing the symptoms now?

What is failed back surgery syndrome?

Failed back surgery syndrome describes persistent or recurrent back pain, leg pain, or both after spinal surgery. The newer term persistent spinal pain syndrome type 2 avoids implying that every painful outcome represents a technical surgical failure. Neither label identifies a single cause. (1)

A fusion can heal while a nearby joint remains painful. A discectomy can relieve pressure on a nerve without reversing every consequence of an earlier nerve injury. Conversely, new symptoms can reflect a complication that needs prompt treatment. These possibilities require different decisions.

How common is persistent pain after back surgery?

Reported rates depend on the operation, follow-up period, and definition of persistent pain. An insurance-database study of 102,047 patients reported a failed back surgery diagnosis in 5.4% within six months and 8.4% within twelve months. Multilevel procedures had higher rates than single-level procedures. These are recorded diagnoses, not a count of everyone with any remaining discomfort. (2)

Another population study found persistent postoperative pain in approximately one in five patients within two years. That estimate should not be converted into a universal failure rate for every spinal procedure. (3)

Improvement and satisfaction are also different outcomes. In a registry study of patients who achieved clinically meaningful improvement in pain or disability, 28% still reported dissatisfaction. Difficulty returning to work and previous physical activity helped explain this gap. A lower pain score may matter less to someone who still cannot manage ordinary daily life. (4)

Outcome studies also need adequate follow-up. A spine-registry study found that people missing from later surveys had worse early outcomes than those who responded. Missing follow-up can make treatment results appear better than they are—a limitation that matters when assessing both surgery and injection studies. (5)

Why can back or leg pain persist after surgery?

The timing and character of symptoms help guide the investigation. Pain that never changed after surgery raises different questions from new leg weakness immediately afterward or a return of pain years later.

Persistent or recurrent nerve compression

Residual spinal stenosis, a recurrent disc herniation, or narrowing around a nerve at another level can cause radiating pain, numbness, or weakness. Arachnoiditis, nerve injury, and other postoperative changes may also contribute. Scar tissue around nerves is one possibility, but seeing scar tissue does not establish that it explains every symptom. (6)

Discectomy usually removes the herniated disc material rather than the entire disc. Recurrence can occur, but persistent symptoms are not proof that too little disc was removed. More extensive surgery also has consequences. Our discussion of sciatica and lumbar radiculopathy explains the distinction between nerve-root pain and other sources of leg pain.

Less invasive surgery can still leave symptoms or require further treatment. In a study of 62,690 lumbar-discectomy patients, 3.3% were readmitted and 2.2% underwent reoperation within thirty days. These are early events, not estimates of long-term failure. (7)

Conversely, a small endoscopic-discectomy series reported excellent or good outcomes in most of its 55 patients. Less favorable results were associated with factors such as smoking and coexisting disease. The useful message is that a less invasive approach does not eliminate the need to identify the appropriate surgical target and assess the patient’s wider circumstances. (8)

Incomplete fusion or a hardware problem

Pseudarthrosis means that the intended bony fusion has not united. It is different from a new fracture and from pain despite a solid fusion. Loose, broken, or malpositioned hardware, infection, and postoperative fluid collections are additional concerns. These findings require appropriate surgical assessment; an injection cannot repair a broken screw or correct a misplaced implant. (6)

Joint, ligament, and tendon-attachment pain

The disc is one potential pain source. Facet joints, sacroiliac joints, and ligament or tendon attachments can also hurt. A painful attachment is called an enthesopathy. Surgery may help one contributor while another remains. (9)

For example, a patient whose leg pain improves after lumbar surgery may continue to have pain near the back of the pelvis. The sacroiliac joint deserves consideration in that setting, alongside hip, lumbar, and nerve-related explanations. Location and tenderness alone are insufficient to identify the source. Read more about sacroiliac joint pain, diagnosis, and treatment.

Pelvic X-ray showing lumbar fusion hardware and the location of both sacroiliac joints
The sacroiliac joints lie near the lower lumbar fusion shown here. This image illustrates their location; the X-ray alone cannot establish that either joint is the pain source.

Muscle weakness, deconditioning, and altered pain processing

Reduced activity can weaken the muscles that support movement. Persistent muscle guarding may accompany painful tissues, but tightness does not prove ligament instability. Rehabilitation may need to address strength, endurance, movement confidence, and the effects of prolonged inactivity.

Changes in pain processing can coexist with structural problems. A 2022 study compared 34 patients with failed back surgery syndrome, 102 postoperative patients without low back pain, and 102 healthy controls. The persistent-pain group had greater pain sensitivity and evidence of reduced pain inhibition. These findings support altered nervous-system pain processing; they do not mean the symptoms are imaginary or establish that surgery caused the changes. (10)

Can surgery change spinal stability or affect adjacent levels?

Decompression removes selected tissues to create space for nerves. The effect on stability depends on the structures removed, the extent of surgery, and the condition of the spine beforehand. Laminectomy, laminotomy, and discectomy are not interchangeable procedures, and postoperative instability is a possibility rather than an inevitable result.

Diagrams and models comparing laminectomy, bilateral laminotomy, and open-door laminoplasty
These diagrams illustrate different approaches to decompression. The effects on supporting tissues vary with the procedure. The open-door laminoplasty example is a distinct operation, commonly used in the cervical spine.

Fusion intentionally stops movement at the operated level. Motion and load are then distributed differently through the remaining spine. Adjacent segment degeneration describes imaging changes near a fusion; adjacent segment disease means those changes are associated with clinical symptoms. These terms should not be used as if every imaging abnormality needs treatment. (11)

In a retrospective series of 902 lumbar-fusion patients, 49 patients—5.4%—underwent another operation for adjacent segment disease during follow-up. This was a reoperation rate, not the proportion with any adjacent degeneration. Higher body mass index, preexisting degeneration, and alignment-related factors were among the concerns identified. (12)

Flexion-extension radiographs can sometimes help assess abnormal movement. A change in alignment or narrowing with movement must be interpreted with symptoms, examination, and the rest of the imaging. It cannot independently prove which tissue hurts or that Prolotherapy will correct the problem.

Problems outside the operated region

Persistent walking difficulty, poor balance, or hand symptoms may warrant assessment beyond the lumbar spine. Cervical, thoracic, and lumbar stenosis can coexist—a pattern called tandem spinal stenosis. Identifying more than one affected region helps avoid attributing every symptom to the level that was operated on. (13)

Our companion article on post-laminectomy symptoms discusses pain after decompression in more detail.

How is persistent pain after spinal surgery evaluated?

A useful assessment considers what operation was performed, whether symptoms changed, and whether the current pain resembles the preoperative problem. Examination can assess strength, sensation, reflexes, walking, and possible hip, pelvic, or joint contributors. Review of the operative records is particularly important when a person has had several procedures.

Different imaging tests answer different questions:

  • Standing radiographs assess alignment and hardware; selected movement views can assess instability.
  • CT provides detailed information about bone, fusion, and hardware.
  • MRI is valuable for nerves, discs, soft tissues, infection, and other postoperative changes. Contrast may help answer particular questions.
  • Specialized imaging, including nuclear-medicine techniques, may be useful when conventional studies leave a specific concern unresolved.

A 2026 imaging review emphasizes matching the test to the suspected complication and interpreting it in clinical context. A normal or inconclusive scan does not invalidate pain, but it also does not automatically establish a ligament diagnosis. (14)

Diagnostic joint injections or nerve blocks may help investigate selected pain sources. Temporary relief is one piece of evidence, rather than a guarantee of long-term treatment success. (15)

New progressive weakness, loss of bladder or bowel control, numbness around the groin, or severe worsening pain with fever requires urgent assessment. A potentially serious postoperative or neurological problem should not wait for an injection-treatment discussion.

Ross Hauser, MD’s research on lumbar instability and Prolotherapy

Dr. Hauser’s work contributes a focused perspective: when persistent pain involves supportive connective tissues, attention should extend beyond the disc and the operated level. His publications include a clinical case series, a systematic review, and a lumbar-instability review. Each provides a different kind of evidence.

The 2022 lumbar-instability review: why spinal ligaments matter

Dr. Hauser and colleagues examined lumbar instability as a potential contributor to low back pain. The review discusses how spinal ligaments, facet joints, discs, muscles, and pelvic structures interact, and how injury or degeneration may change those relationships. It also reviews Prolotherapy and PRP as potential treatments for selected patients. (16)

This provides the anatomical and clinical rationale behind our interest in painful ligament attachments and instability after surgery. It is particularly relevant when fusion has addressed one problem but pain may remain in another structure.

However, this is a narrative review, not a randomized trial of patients with failed fusion. It does not establish that ligament injury explains most postoperative pain, that injections restore a failed bony fusion, or that treating a ligament prevents adjacent segment disease. Its value is in bringing a potentially overlooked contributor into the diagnostic discussion. (16)

The 2009 low-back-pain study: patient-reported improvement

Ross Hauser, MD and Marion Hauser reported a retrospective case series of 145 people with unresolved low back pain. Participants had experienced pain for an average of four years and ten months and were contacted an average of twelve months after their last treatment. Reported average pain decreased from 5.6 to 2.7. Improvements in walking, exercise, and other daily activities were also reported. (17)

The study included 55 patients who said they had been told there were no other treatment options and 26 who said surgery was their only option. Those histories make the findings relevant to people seeking another approach after prolonged symptoms.

The study had no control group and relied on patients recalling their condition before treatment. It was not a dedicated study of pain after fusion, and it did not establish that injections prevented surgery or objectively repaired spinal ligaments. The results are encouraging observational findings that support further controlled research. (17)

The 2016 systematic review: broader evidence, condition-specific conclusions

Dr. Hauser and coauthors reviewed 33 studies of dextrose Prolotherapy: 14 randomized trials, one case-control study, and 18 case series. They reported supportive evidence for several musculoskeletal conditions, including selected spinal and pelvic pain associated with ligament dysfunction. (18)

The findings should be applied to the condition actually studied. A positive knee or tendon trial cannot establish effectiveness after spinal fusion. Even within spinal pain research, injection locations, concentrations, diagnoses, and accompanying treatments differ.

These publications support discussing Prolotherapy as a possible option for selected patients. They do not provide a universal success rate for failed back surgery syndrome or establish that PRP plus Prolotherapy is superior to either alone after surgery. (18)

What studies specifically address Prolotherapy after back surgery?

A 2019 case series of 79 patients

A consecutive case series studied 79 patients with failed back surgery syndrome whose symptoms had lasted at least six months and had not responded to three months of conservative treatment. The researchers used 5% dextrose injections and reported improvements in pain and disability. (19)

This is directly relevant to postoperative pain, but there was no randomized comparison group. The study cannot separate the injection effect from other influences or establish that improvement resulted from ligament strengthening. Low-concentration dextrose treatment should not automatically be described as equivalent to higher-concentration ligament Prolotherapy.

Research on painful tendon and ligament attachments

A small randomized, single-blind crossover study included 35 patients with painful attachment sites; 86% had undergone prior lumbar surgery. It compared local anesthetic injections with anesthetic plus a phenol-glycerol proliferant—not dextrose alone. Patient-reported good-to-excellent relief favored the proliferant injections, but average relief generally lasted months rather than years. (9)

Only four patients subsequently underwent additional surgery, while 29 requested further injections. Without an appropriate surgical comparison, those figures do not prove that surgery was prevented. The study supports considering painful attachments as a contributor, while leaving substantial uncertainty about durable outcomes.

A 2024 epidural trial: the injection target matters

A randomized double-blind trial assigned 90 patients with failed back surgery syndrome to caudal epidural 10% dextrose or steroid injections. Both groups improved from baseline. Steroids produced better pain scores at eight weeks, three months, and six months, with disability outcomes also favoring steroids at later assessments. (20)

This was an epidural procedure, not treatment of multiple spinal ligament attachments. Its results should neither be omitted nor presented as a direct test of our ligament-focused approach.

An earlier Cochrane review found that Prolotherapy alone did not outperform control injections in three chronic-low-back-pain trials. Two trials combining injections with exercise, manipulation, or other treatments reported benefits, but those accompanying treatments made the injection effect difficult to isolate. This older evidence helps explain why newer positive findings should be interpreted carefully rather than treated as a settled answer. (21)

New 2026 research: Prolotherapy compared with epidural steroids

A pragmatic randomized trial analyzed 104 participants with chronic low back pain and associated leg pain. Dextrose Prolotherapy produced better pain and disability scores than epidural steroid injections at six and twelve months. At twelve months, average pain scores were 5.2 versus 6.9 on a ten-point scale—an improvement, with substantial pain still present on average. (22)

The trial was unblinded and allowed up to five monthly Prolotherapy treatments versus three steroid treatments. It was not a trial specifically establishing benefit for patients with spinal fusion, nor a test of PRP combined with Prolotherapy. It is a useful newer finding that requires attention to treatment differences and patient selection.

A separate 2026 systematic review included twelve spinal-pain studies, most of them nonrandomized. It reported promising pain and functional outcomes, including in postoperative populations. Differences in diagnosis, concentration, and technique limit firm conclusions. No major complications were reported in the included studies, but small studies cannot reliably exclude uncommon harms. (23)

Why we consider PRP and Prolotherapy together

At Caring Medical, we use PRP with dextrose Prolotherapy in selected patients to address painful ligament and tendon attachments. Dextrose Prolotherapy is intended to stimulate a local repair response. PRP is prepared from the patient’s blood and contains concentrated platelets and signaling proteins involved in healing.

The rationale is to address potentially painful supporting tissues as part of the overall mechanical problem. It is a clinical approach, not proof that the combination produces better postoperative outcomes. Our article on PRP and Prolotherapy for lower back pain explains the treatment concept and research limitations.

PRP studies must be separated by target. Injection into a disc, a facet joint, or a ligament attachment—and PRP applied during fusion surgery—are different interventions.

A 2026 review of eleven randomized trials involving 623 patients with disc-related low back pain found no significant pooled advantage for PRP over comparison treatments for pain or function. Evidence certainty was very low, and PRP preparation was inconsistently described. Two serious adverse events were reported following PRP treatment. This review does not directly evaluate combined ligament Prolotherapy and PRP after fusion, but it cautions against broad claims for spinal PRP. (24)

A 2026 randomized facet-joint study of 76 patients also did not demonstrate PRP superiority over corticosteroids for its six-month outcomes. (25)

Research on using PRP to improve the surgical fusion itself is another separate question. A systematic overview published in its 2022 journal issue did not support PRP as an adjunct to enhance spinal fusion. It should not be cited as evidence that injections repair a fusion that has not united. (26)

Injections also have risks, including temporary pain flares, bleeding, infection, and injury to nearby structures. Previous surgery changes the anatomy, and the presence of hardware or an implanted device matters when considering any procedure. Treatment selection requires more than a general diagnosis of failed back surgery syndrome.

Derek’s experience: persistent pain after fusion and hardware removal

In this video, Derek talks with Danielle Mus about undergoing fusion at approximately age 24, continuing to have symptoms, and seeking additional treatment. He describes physically demanding work as a funeral director and later in tree service, and the importance of being able to remain active.

Several treatments contributed to his recovery experience

Derek recalls some benefit from Prolotherapy with Dr. Hauser while rods and screws were still present. He later received PRP and treatments described in the interview as stem cell injections, reporting greater benefit as care progressed. He subsequently underwent hardware removal in Indiana and says that this helped considerably, although symptoms remained. He then continued injection treatment with Danielle Mus.

His account reflects several interventions over years. It cannot isolate the effect of any one injection or establish a general progression from a weaker to a stronger treatment. Hardware removal does not undo a mature bony fusion or restore normal movement at the fused level, and his improvement does not justify routine removal in other patients.

Reported periods of relief and improved quality of life

Derek reports that some later injections were followed by approximately three years of relief before he sought treatment again. At the interview, he describes less pain and the ability to continue physical work. His return visit followed symptoms recurring; it is not evidence for a standard three-year maintenance schedule.

The interview does not identify the exact cell preparation, processing, dose, or injection sites. It also provides no standardized pain scores or comparison group. His improvement is a valuable patient experience, but does not establish disc regeneration, reversal of fusion, or prevention of future surgery.

A 2025 sham-controlled trial of intradiscal bone marrow concentrate in 63 patients found no significant between-group differences in pain or disability outcomes through twelve months. Limited cell characterization complicated interpretation. That was a different, specified procedure—not a study of Derek’s unidentified preparation or treatment after fusion. (27)

The FDA has not approved stem cell products for treating back pain or disc disease. A treatment’s contents and regulatory status cannot be determined from the phrase “stem cell therapy” alone. (28)

What other treatments can help after back surgery?

Treatment should match the suspected pain mechanism and the patient’s circumstances. A 2024 umbrella review found considerable variation in the evidence and supported conservative management before escalation in appropriate patients. It identified neurostimulation as a potentially useful option for selected refractory cases, rather than a solution for every postoperative pain pattern. (29)

Rehabilitation and support for persistent pain

Physical rehabilitation can address deconditioning, walking tolerance, movement control, and strength. Persistent pain does not mean that all movement is damaging, although exercises may need adjustment when they repeatedly aggravate symptoms. Spine-specific restrictions following surgery remain relevant.

Sleep, depression, anxiety, and fear of movement also deserve attention. Psychological support is treatment for the burden and nervous-system effects of pain; it does not require dismissing a structural problem. A systematic review found that preoperative pain-related fear was not a reliable predictor of postoperative pain or function, with mixed evidence for other relationships. Blaming an unsuccessful result on a patient’s attitude is not justified. (30)

A review of mindfulness research found mixed results and generally low-quality evidence. Mindfulness may help some patients manage chronic musculoskeletal pain, but it does not repair hardware, decompress a nerve, or establish the source of back pain. (31)

A 2026 database study of 603,272 surgical patients associated persistent postoperative pain indicators with later psychiatric and neurological diagnoses and mortality. The definitions included diagnosis codes, prolonged gabapentinoid use, or reoperation, rather than a single clinical pain assessment. These associations do not prove that back pain causes dementia or that injections reduce those risks. They underline the importance of taking ongoing pain and its wider effects seriously. (32)

Medications, epidural injections, and targeted procedures

Medication may reduce pain or support activity while the cause is investigated. Epidural injections may be considered for selected nerve-related pain; facet procedures or sacroiliac interventions address different targets. Adhesiolysis is sometimes considered when epidural adhesions are suspected. Benefits, risks, and durability vary, and repeated treatment should not replace reconsideration of an uncertain diagnosis. (29)

Opioids require particular care. A large observational study associated preoperative opioid exposure with prolonged postoperative use and several complications. Association does not establish that opioids caused every poor outcome, and physical dependence is not synonymous with addiction. People taking prescribed opioids should not stop abruptly; changes require medical supervision. (33)

Spinal cord stimulation

A spinal cord stimulator delivers electrical signals through implanted leads to influence pain signaling. It does not mechanically stabilize a spine, remove compression, or heal a failed fusion.

Evidence depends on the population, comparator, and follow-up. A 2023 Cochrane review of low back pain trials found no meaningful advantage over placebo at six months in the available study and highlighted inadequate long-term placebo-controlled evidence. These findings should be considered alongside the more favorable findings in some selected postoperative populations. (34)

A 2026 review pooled invasive and noninvasive neuromodulation trials after lumbar surgery and found improvements in pain and analgesic consumption, but not a significant disability benefit. Its mixed interventions and acute and chronic populations mean that its results are not proof of durable benefit from an implanted stimulator alone. (35)

Device complications, lead movement, infection, and loss of benefit can require further procedures. In a small retrospective series of 45 patients, opioid doses rose in 40%, fell in 40%, and were unchanged in 20% after one year; 27% later underwent device removal for treatment failure. These figures describe that selected series, not every modern device or patient. (36)

Intrathecal drug delivery

An implanted pump delivers medication into the fluid space around the spinal cord. It may reduce the need for systemic medication in selected people with otherwise difficult-to-control pain, but requires ongoing management and carries medication and device risks.

In a single-center survey completed by 443 active pump patients, most reported improvement in pain and quality of life; 38.9% reported stopping oral opioids. Because this was a survey of people still using pumps, it cannot establish comparative effectiveness or represent everyone who tried the treatment. (37)

When might another operation be appropriate?

Revision surgery may be appropriate for a clearly identified problem such as progressive neurological impairment, significant recurrent compression, symptomatic nonunion, infection, or hardware failure. Persistent pain alone does not establish which operation would help. Equally, the possibility of injection treatment should not delay necessary decompression or correction of a serious complication. (15)

Reoperation statistics need context. One nationwide lumbar-stenosis cohort reported cumulative reoperation rates of 6.2% at two years, 10.8% at five years, and 18.4% at ten years. The initial surgical technique did not significantly affect the overall long-term reoperation risk. Those findings do not mean that everyone with fusion eventually needs another operation. (38)

Osteoporosis and diabetes were associated with early reoperation in a separate lumbar-fusion cohort, while multilevel fusion was associated with later reoperation. These findings help explain why the condition of the patient and the extent of surgery matter alongside the diagnosis. (39)

A systematic review of thirty-day readmission risk also identified factors such as frailty, malnutrition, anemia, cardiopulmonary disease, and postoperative complications. These are potential risk factors rather than a certainty of poor recovery for any individual. (40)

How we view Prolotherapy after spinal surgery

Our clinical perspective is that painful supporting tissues deserve consideration when a person continues to struggle after surgery. Dr. Hauser discusses that perspective in these videos, including the possibility of an untreated sacroiliac problem, altered mechanics, a second pain source, deconditioning, or postoperative nerve-related pain. These are possible contributors, not diagnoses established by the videos.

Prolotherapy may be considered when the clinical findings support a painful ligament or attachment-related problem. It is not a treatment for every source of postoperative pain, and the available research does not justify promising a particular percentage of relief or a cure.

For a broader discussion, see Prolotherapy for low back pain and lumbar instability. For symptoms dominated by spinal narrowing, our article on lumbar spinal stenosis explains when nonsurgical care and surgical assessment may be appropriate.

The practical goal is to identify the remaining pain source accurately enough to make a reasonable treatment decision. A healed fusion, ongoing nerve pain, a painful sacroiliac joint, and a damaged ligament are different problems. Recognizing that distinction gives patients a clearer basis for considering their next step.

This information is educational and does not replace an individual medical assessment. Results vary. Patient experiences and observational studies cannot predict the benefits or risks of a particular treatment for another person.

References

1 Yeo J. Failed back surgery syndrome-terminology, etiology, prevention, evaluation, and management: a narrative review. J Yeungnam Med Sci. 2024;41(3):166-178. doi:10.12701/jyms.2024.00339. [Google Scholar]

2 Stanton EW, Chang KE, Formanek B, Buser Z, Wang J. The incidence of failed back surgery syndrome varies between clinical setting and procedure type. J Clin Neurosci. 2022;103:56-61. doi:10.1016/j.jocn.2022.06.027. [Google Scholar]

3 Weir S, Samnaliev M, Kuo TC, Tierney TS, Manca A, Taylor RS, Bruce J, Eldabe S, Cumming D. Persistent postoperative pain and healthcare costs associated with instrumented and non-instrumented spinal surgery: a case-control study. J Orthop Surg Res. 2020;15(1):127. doi:10.1186/s13018-020-01633-6. [Google Scholar]

4 Sivaganesan A, Khan I, Pennings JS, Roth SG, Nolan ER, Oleisky ER, Asher AL, Bydon M, Devin CJ, Archer KR. Why are patients dissatisfied after spine surgery when improvements in disability and pain are clinically meaningful? Spine J. 2020;20(10):1535-1543. doi:10.1016/j.spinee.2020.06.008. [Google Scholar]

5 Mannion AF, Fekete TF, O’Riordan D, Loibl M, Kleinstück FS, Porchet F, Reitmeir R, Jeszenszky D, Haschtmann D. Does loss to follow-up lead to an overestimation of treatment success? Findings from a spine surgery registry of over 15,000 patients. Eur Spine J. 2023;32(3):813-823. doi:10.1007/s00586-023-07541-7. [Google Scholar]

6 Rankine JJ. The postoperative spine. Semin Musculoskelet Radiol. 2014;18(3):300-8. doi:10.1055/s-0034-1375571. [Google Scholar]

7 Samuel AM, Morse K, Lovecchio F, Maza N, Vaishnav AS, Katsuura Y, Iyer S, McAnany SJ, Albert TJ, Gang CH, Qureshi SA. Early Failures After Lumbar Discectomy Surgery: An Analysis of 62 690 Patients. Global Spine J. 2021;11(7):1025-1031. doi:10.1177/2192568220935404. [Google Scholar]

8 Katzell JL. Risk factors predicting less favorable outcomes in endoscopic lumbar discectomies. J Spine Surg. 2020;6(Suppl 1):S155-S164. doi:10.21037/jss.2019.11.04. [Google Scholar]

9 Wilkinson HA. Injection therapy for enthesopathies causing axial spine pain and the “failed back syndrome”: a single blinded, randomized and cross-over study. Pain Physician. 2005;8(2):167-73. [Google Scholar]

10 Nie C, Chen K, Chen J, Zhu Y, Jiang J, Jin X, Xia X, Zheng C. Altered central pain processing assessed by quantitative sensory testing in patients with failed back surgery syndrome. Neurophysiol Clin. 2022;52(6):427-435. doi:10.1016/j.neucli.2022.10.005. [Google Scholar]

11 Rubio-Haro R, DE Andrés-Serrano C, Noriega González DC, Bordes-García C, DE Andrés J. Adjacent segment syndrome after failed back surgery: biomechanics, diagnosis, and treatment. Minerva Anestesiol. 2022;88(4):282-292. doi:10.23736/S0375-9393.21.15939-5. [Google Scholar]

12 Cannizzaro D, Anania CD, De Robertis M, Pizzi A, Gionso M, Ballabio C, Ubezio MC, Frigerio GM, Battaglia M, Morenghi E, Capo G, Milani D, Attuati L, Tomei M, Riva M, Costa F, Galbusera F, Politi LS, Ortolina A, Fornari M. The lumbar adjacent-level syndrome: analysis of clinical, radiological, and surgical parameters in a large single-center series. J Neurosurg Spine. 2023;39(4):479-489. doi:10.3171/2023.5.SPINE235. [Google Scholar]

13 Bai Q, Wang Y, Zhai J, Wu J, Zhang Y, Zhao Y. Current understanding of tandem spinal stenosis: epidemiology, diagnosis, and surgical strategy. EFORT Open Rev. 2022;7(8):587-598. doi:10.1530/EOR-22-0016. [Google Scholar]

14 Budzik JF, Musset T, Lefebvre G, Legrand J, Decaudain J, Ducoulombier V, Verclytte S. Imaging persistent spinal pain syndrome and spine surgery complications: an interpretation guide for radiologists. Insights Imaging. 2026;17(1):26. doi:10.1186/s13244-025-02065-8. [Google Scholar]

15 Hussain A, Erdek M. Interventional pain management for failed back surgery syndrome. Pain Pract. 2014;14(1):64-78. doi:10.1111/papr.12035. [Google Scholar]

16 Hauser RA, Matias D, Woznica D, Rawlings B, Woldin BA. Lumbar instability as an etiology of low back pain and its treatment by prolotherapy: A review. J Back Musculoskelet Rehabil. 2022;35(4):701-712. doi:10.3233/BMR-210097. [Google Scholar]

17 Hauser RA, Hauser MA. Dextrose Prolotherapy for Unresolved Low Back Pain: A Retrospective Case Series Study. Journal of Prolotherapy. 2009;1(3):145-155. [Google Scholar]

18 Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:139-59. doi:10.4137/CMAMD.S39160. [Google Scholar]

19 Solmaz İ, Akpancar S, Örsçelik A, Yener-Karasimav Ö, Gül D. Dextrose injections for failed back surgery syndrome: a consecutive case series. Eur Spine J. 2019;28(7):1610-1617. doi:10.1007/s00586-019-06011-3. [Google Scholar]

20 Mohamed YRE, El-Attar AMI, Anwar DMF, Shehab ASA. The efficacy of ultrasound and fluoroscopy-guided caudal epidural prolotherapy versus steroids for chronic pain management in failed back surgery syndrome. Alexandria Journal of Medicine. 2024;60(1):238-243. doi:10.1080/20905068.2024.2387884. [Google Scholar]

21 Dagenais S, Yelland MJ, Del Mar C, Schoene ML. Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev. 2007;2007(2):CD004059. [Google Scholar]

22 Wende O, Reeves KD, Vishnevsky G, Cheng AL, Rabago D. Prolotherapy versus epidural steroid injections for lumbar pain with associated leg pain: A pragmatic randomized controlled trial. PM R. 2026 [published online]. doi:10.1002/pmrj.70136. [Google Scholar]

23 Nazwar TA, Bal’afif F, Wardhana DW, Bal’afif F, Panjaitan C. Effectiveness and safety of dextrose prolotherapy for chronic spinal pain: A systematic review. J Anaesthesiol Clin Pharmacol. 2026;42(3):332-344. doi:10.4103/joacp.joacp_524_25. [Google Scholar]

24 Madrazo-Ibarra A, de la Huerta-Meza D, Gutierrez-Naranjo JM, Kirschner JS. Preparation methods and clinical outcomes of platelet-rich plasma for chronic discogenic low back pain: A systematic review and meta-analysis of randomized controlled trials. PM R. 2026 [published online]. doi:10.1002/pmrj.70216. [Google Scholar]

25 Geoffroy M, Beissat M, Kanagaratnam L, Ackah Miezan S, Salmon JH. Platelet-rich plasma versus corticosteroids in facet joint syndrome: A controlled, randomized, double-blind study. Joint Bone Spine. 2026;93(3):106001. doi:10.1016/j.jbspin.2025.106001. [Google Scholar]

26 Muthu S, Jeyaraman M, Ganie PA, Khanna M. Is Platelet-Rich Plasma Effective in Enhancing Spinal Fusion? Systematic Overview of Overlapping Meta-Analyses. Global Spine J. 2022;12(2):333-342. doi:10.1177/2192568220988278. [Google Scholar]

27 Levi D, Tyszko S, Horn S, Pham N, Levin J. Bone marrow concentrate intradiscal injection for chronic discogenic low back pain: A double-blind randomized sham-controlled trial. Interv Pain Med. 2025;4(3):100611. doi:10.1016/j.inpm.2025.100611. [Google Scholar]

28 U.S. Food and Drug Administration. Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. July 22, 2020. [Google Scholar]

29 Gallego H, Arango S, Combalia A, Fuster S, Jaramillo C, Herrera AM. Treatment Options for Failed Back Surgery Syndrome: An Umbrella Systematic Review of Systematic Reviews on the Effectiveness of Therapeutic Interventions. Spine Surg Relat Res. 2024;8(2):143-154. doi:10.22603/ssrr.2023-0032. [Google Scholar]

30 Van Bogaert W, Tegner H, Coppieters I, Huysmans E, Nijs J, Moens M, Goudman L, Buyl R, Lundberg M. The Predictive Value of Fear Avoidance Beliefs for Outcomes Following Surgery for Lumbar Degenerative Disease: A Systematic Review and Best Evidence Synthesis. Pain Physician. 2022;25(6):441-457. [Google Scholar]

31 Cardle P, Kumar S, Leach M, McEvoy M, Veziari Y. Mindfulness and Chronic Musculoskeletal Pain: An Umbrella Review. J Multidiscip Healthc. 2023;16:515-533. doi:10.2147/JMDH.S392375. [Google Scholar]

32 Park D, Lee WR, Bang M, Park SJ, Kim JH, Kim HS. Impact of Postoperative Chronic Back Pain Syndrome on the Incidence of Psychiatric and Brain Disorders, and All-Cause Mortality. J Pain Res. 2026;19:582506. doi:10.2147/JPR.S582506. [Google Scholar]

33 Kowalski C, Ridenour R, McNutt S, Ba D, Liu G, Bible J, Aynardi M, Garner M, Leslie D, Dhawan A. Risk Factors For Prolonged Opioid Use After Spine Surgery. Global Spine J. 2023;13(3):683-688. doi:10.1177/21925682211003854. [Google Scholar]

34 Traeger AC, Gilbert SE, Harris IA, Maher CG. Spinal cord stimulation for low back pain. Cochrane Database Syst Rev. 2023;3(3):CD014789. doi:10.1002/14651858.CD014789.pub2. [Google Scholar]

35 Penchev P, Milanova-Ilieva D, Gaydarski L, Dimitrov D, Tablov B, Husain N, Hyusein R, Vladimirov C, Mihaylova M, Lozanov I, Stavrev D, Petrov PP, Stanchev P, Velev A, Ramadanov N, Peev N. Efficacy of Neuromodulation in Postoperative Acute and Chronic Low Back Pain after Lumbar Spine Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Trial Sequential Analysis and Meta-Regression. J Clin Neurosci. 2026;144:111815. doi:10.1016/j.jocn.2025.111815. [Google Scholar]

36 Hwang BY, Negoita S, Duy PQ, Tesay Y, Anderson WS. Opioid use and spinal cord stimulation therapy: The long game. J Clin Neurosci. 2021;84:50-52. doi:10.1016/j.jocn.2020.12.004. [Google Scholar]

37 Schultz DM, Orhurhu V, Khan F, Hagedorn JM, Abd-Elsayed A. Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study. Neuromodulation. 2020;23(7):1009-1017. doi:10.1111/ner.13167. [Google Scholar]

38 Jung JM, Chung CK, Kim CH, Choi Y, Kim MJ, Yim D, Yang SH, Lee CH, Hwang SH, Kim DH, Yoon JH, Park SB. The Long-term Reoperation Rate Following Surgery for Lumbar Stenosis: A Nationwide Sample Cohort Study With a 10-year Follow-up. Spine (Phila Pa 1976). 2020;45(18):1277-1284. doi:10.1097/BRS.0000000000003515. [Google Scholar]

39 Wang SK, Wang P, Li XY, Kong C, Niu JY, Lu SB. Incidence and risk factors for early and late reoperation following lumbar fusion surgery. J Orthop Surg Res. 2022;17(1):385. doi:10.1186/s13018-022-03273-4. [Google Scholar]

40 Chen LY, Chang Y, Wong CE, Chi KY, Lee JS, Huang CC, Lee PH. Risk Factors for 30-day Unplanned Readmission following Surgery for Lumbar Degenerative Diseases: A Systematic Review. Global Spine J. 2023;13(2):563-574. doi:10.1177/21925682221116823. [Google Scholar]

 

Get Help Now!

You deserve the best possible results from your treatment. Let’s make this happen! Talk to our team about your case to find out if you are a good candidate.